Interindividual Variation in Excretion of Curcumin

University of Massachusetts Amherst

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03746158

Enrollment

Registered

2018-11-19

Start date

2018-09-01

Completion date

2019-10-01

Last updated

2020-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gut Microbiota, Metabolites

Brief summary

The objective of this project is to elucidate the interindividual variations in excretion of curcumin and its metabolites.

Interventions

DIETARY_SUPPLEMENTcurcumin

subjects will be assigned to consume one capsule of curcumin (330 mg of curcumin per capsule) three times a day (one capsule with each meal).

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 30 Years

Healthy volunteers

Yes

Inclusion criteria

* 18-30 year old healthy adults

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Determine the concentration of curcumin and its metabolites in the human fecal samples.	3-4 weeks	Utilize LC-MSMS to identify and quantify the curcumin and its metabolites in the subjects fecal samples.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026